Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
IVERIC bio Reports Second Quarter 2020 Operational Highlights and Financial Results
11:00am, Wednesday, 05'th Aug 2020
IVERIC bio today announced the financial and operating results for the fiscal quarter ended June 30, 2020 and provided a general business update.
IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
12:00pm, Tuesday, 04'th Aug 2020
IVERIC bio announced Pravin Dugel, MD will present an overview of the Company at the Wedbush PacGrow Healthcare Virtual Conference on Aug. 12, 2020.
World Retinal Biologics Market: Growth, Trends and Forecasts (2020-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10:55pm, Monday, 03'rd Aug 2020
IVERIC bio reported that the Company granted Dhaval Desai, Chief of Staff, equity based awards pursuant to the 2019 Inducement Stock Incentive Plan.
Worsening eye sight doesn't stop for Covid, neither did we
05:05am, Friday, 31'st Jul 2020
New campaign urges Irish public to keep eye care appointments and be vigilant for signs of age-related macular degeneration
IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020
12:00pm, Wednesday, 29'th Jul 2020
IVERIC bio today announced that it will report its second quarter 2020 financial and operating results on Wednesday, August 5, 2020.
What You Need To Know About IVERIC bio, Inc.'s (NASDAQ:ISEE) Investor Composition
07:49pm, Monday, 27'th Jul 2020
If you want to know who really controls IVERIC bio, Inc. (NASDAQ:ISEE), then you'll have to look at the makeup of its...
Did Hedge Funds Make The Right Call On IVERIC bio, Inc. (ISEE) ?
02:36pm, Friday, 17'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
IVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors
12:00pm, Thursday, 16'th Jul 2020
IVERIC bio announced the election of Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors, effective as of July 15, 2020.
Two Sigma Advisers LP Has $258,000 Stock Position in IVERIC bio Inc (NASDAQ:ISEE)
04:18am, Sunday, 12'th Jul 2020
Two Sigma Advisers LP boosted its stake in shares of IVERIC bio Inc (NASDAQ:ISEE) by 173.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 75,000 shares o
17,273 Shares in IVERIC bio Inc (NASDAQ:ISEE) Purchased by JPMorgan Chase & Co.
06:18am, Wednesday, 08'th Jul 2020
JPMorgan Chase & Co. bought a new position in shares of IVERIC bio Inc (NASDAQ:ISEE) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 17,273 sha
Moving Average Crossover Alert: IVERIC bio
10:31am, Friday, 03'rd Jul 2020
IVERIC bio, Inc. (ISEE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Iveric's Trial Progress And Other News: The Good, Bad And Ugly Of Biopharma
03:14am, Thursday, 02'nd Jul 2020
Iveric Bio commences second pivotal trial. Rubius offers data for RTX-240. Zynerba flunks Fragile X Syndrome trial.
